Device Trial Radar · NCT04084041
Efficacy of Simeox Airway Clearance Therapy in Children With Cystic Fibrosis
Last checked: Nov 20, 2026Latest source record: Sep 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Sep 10, 2019
Primary completion
Jan 31, 2021
Study completion Feb 15, 2021
Sponsor
- Lead sponsor
- Physio-AssistNot on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 10, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 8 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Chest physiotherapy plays a crucial role in treatment of lung disease in cystic fibrosis (CF). New airway clearance techniques (ACTs) adapted to individual needs are still being sought to achieve the best effect of airway clearance. The primary aim of this study is to assess the efficacy of a new ACT (Simeox) on pulmonary function in children with CF. 40 CF patients with stable respiratory function will be randomized 1:1 to Simeox or conventional chest physiotherapy (CCPT) therapy (control group) and treated at home during 1 month. After a short washout period, patients will be treated at home onto the alternative treatment for 1 month (crossover design). Lung function, quality of life, pulmonary exacerbation and safety will be evaluated at 1 month for each therapy period.
Conditions
- Cystic Fibrosis in Children
- Airway Clearance Impairment
Interventions
SimeoxDevice
Airway clearance device
CCPTOther
Conventional chest physiotherapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in total lung resistanceTime frame: 1 month
Locations
1 site in 1 country. Site status is shown where the registry gives one.
IMiD
Warsaw, Poland
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.